Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Mupirocin for Prevention of S. Aureus Infections
NCT00156377Phase 4Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Nov 2002
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mupirocin in Staphylococcus aureus infection, sponsored by Universitätsklinikum Münster. Started Nov 2002; status: completed.
02
Drugs
mupirocin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00156377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156377.